Skip to main content
LUNG logo

Pulmonx Corporation

LUNGNASDAQHealthcareMedical Devices

$2.52Today:- (-)1Y +18.24%

As of Oct 28, 2026 close

Market cap
$107.02M
P/E (TTM)
-
Forward P/E
-
Dividend yield
-
52-week range
$1.13$2.89
Volume (live)
-
Avg. volume (3M)
521.33K

Pulmonx (LUNG) Balance Sheet

As of Dec 31, 2025 (end of fiscal 2025), Pulmonx reported total assets of $129.29M and total liabilities of $75.17M. Shareholders' equity was $54.12M, down 36.9% from $85.81M a year earlier. Total debt stood at $37.09M against $69.75M in cash and short-term investments, a net cash position of $32.66M. That puts debt-to-equity at 0.69, compared with 0.43 a year earlier.

Pulmonx Balance Sheet Analysis

Values in millions USD

Scroll to see more
Balance sheet showing assets, liabilities, and shareholders' equity for Pulmonx Corporation (LUNG) - Annual data in millions USD
BreakdownFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018
Period endingDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018
Current Assets
Cash and Cash Equivalents69.7570.9183.55101.74148.48231.7914.774.12
Short-Term Investments0.0030.5833.5639.4031.560.0013.580.00
Cash & Short-Term Investments69.75101.48117.10141.14180.04231.7928.354.12
Accounts Receivable12.0713.1213.028.686.564.576.003.42
Inventory15.8516.9216.7414.5616.2910.745.613.32
Other Current Assets3.761.133.564.344.882.891.110.44
Total Current Assets101.68136.25150.42168.95208.00249.9941.0711.31
Non-Current Assets
Property, Plant & Equipment (Net)20.2521.457.4310.5012.8910.457.460.38
Long-Term Investments0.000.0014.395.9210.940.000.000.00
Goodwill2.332.332.332.332.332.332.332.33
Intangible Assets0.700.000.030.150.280.400.520.65
Other Non-Current Assets1.422.823.170.530.730.542.140.35
Total Non-Current Assets27.6126.6027.3624.7227.1713.7212.463.71
Total Assets129.29162.85177.78193.68235.17263.7153.5315.01
Current Liabilities
Accounts Payable3.913.831.501.761.581.472.681.29
Short-Term Debt0.113.185.230.090.092.240.450.00
Current Portion of Long-Term Debt-3.182.160.090.09---
Accrued Liabilities14.568.757.6013.2813.378.65--
Deferred Revenue0.020.140.100.120.160.070.170.14
Other Current Liabilities0.260.0516.230.020.158.659.875.91
Total Current Liabilities20.0624.4423.1618.4917.5512.5314.168.07
Non-Current Liabilities
Long-Term Debt36.9934.0036.2017.2317.3224.99226.7133.61
Deferred Tax Liabilities0.070.090.110.090.040.060.040.05
Other Non-Current Liabilities0.070.090.000.090.220.000.00140.61
Total Non-Current Liabilities55.1252.6036.3121.1824.3825.05226.75174.27
Total Liabilities75.1877.0459.4739.6741.9337.57240.91182.34
Stockholders' Equity
Common Stock0.040.040.040.040.040.040.020.02
Retained Earnings-521.56-467.56-411.16-350.32-291.40-242.73-210.50-189.80
Accumulated Other Comprehensive Income2.362.112.641.581.711.691.371.33
Additional Paid-in Capital573.27551.21526.80502.71482.89467.1521.7521.12
Shares Outstanding41.6739.7938.5237.5636.93---
Total Stockholders' Equity54.1285.81118.32154.01193.24226.13-187.38-167.33
Total Liabilities & Equity129.29162.85177.78193.68235.17263.7153.5315.01

Source: Company financial statements from annual and quarterly filings. Data as of Jun 30, 2026. Data sources and methodology

Frequently Asked Questions About Pulmonx Balance Sheet

How much debt does Pulmonx have?

Pulmonx had total debt of $37.09M as of Dec 31, 2025, against $69.75M in cash and short-term investments. Its debt-to-equity ratio was 0.69. Total debt was $37.18M a year earlier.

What are Pulmonx's total assets?

Pulmonx reported total assets of $129.29M as of Dec 31, 2025, down 20.6% from $162.85M a year earlier. Total liabilities were $75.17M.

What is Pulmonx's shareholders' equity?

Pulmonx's shareholders' equity was $54.12M as of Dec 31, 2025, or about $1.30 of book value per share.

What is the debt-to-equity ratio?

The debt-to-equity ratio divides a company's total debt by its shareholders' equity. It shows how much of the business is financed with borrowed money; normal levels vary widely by industry. Full definition